WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Introducing ALZET?ew Model 2006 Pump
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 8, 2006, 26(45):11540-11553; doi:10.1523/JNEUROSCI.3507-06.2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in J. Neurosci.
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lau, A.
Right arrow Articles by Tymianski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lau, A.
Right arrow Articles by Tymianski, M.

 Previous Article  |  Next Article 

Neurobiology of Disease
Inhibition of Caspase-Mediated Apoptosis by Peroxynitrite in Traumatic Brain Injury

Anthony Lau,1,2 Mark Arundine,1,2 Hong-Shuo Sun,1,2 Michael Jones,1,2 and Michael Tymianski1,2

1Division of Applied and Interventional Research, Toronto Western Research Institute, Toronto, Ontario, Canada M5T 2S8, and 2Departments of Physiology and 3Neurosurgery, University of Toronto, Toronto, Ontario, Canada M5S 1A8

Correspondence should be addressed to Dr. Michael Tymianski, Fellow of the Royal College of Surgeons of Canada, Toronto Western Hospital, WW 4-435, 399 Bathurst Street, Toronto, Ontario, Canada M5T 2S8. Email: mike.tymianski{at}uhn.on.ca

In traumatic brain injury (TBI), neurons surviving the primary insult may succumb through poorly understood secondary mechanisms. In vitro, cortical neurons exposed to stretch injury exhibited enhanced vulnerability to NMDA, apoptotic-like DNA fragmentation, peroxynitrite (PN) formation, and cytoplasmic cytochrome c accumulation. Surprisingly, caspase-3 activity was undetectable by both immunoblotting and fluorogenic activity assays. Therefore, we hypothesized that PN directly inhibits caspases in these neurons. Consistent with this, stretch injury in cultured neurons elicited tyrosine nitration of procaspase-3, but not caspase-9 or Apaf-1, suggesting a direct interaction of PN with caspase-3. In an ex vivo system, PN inhibited the activity of caspase-3, and this inhibition was reversible with the addition of the sulfhydryl reducing agent dithiothreitol, indicating that PN inhibits caspases by cysteinyl oxidation. Moreover, in cultures, the PN donor 3-morpholinosydnonimine (SIN-1) blocked staurosporine-induced caspase-3 activation and its downstream effects including PARP-1 [poly-(ADP-ribose) polymerase-1] cleavage and phosphotidylserine inversion, suggesting that peroxynitrite can inhibit caspase-3-mediated apoptosis. To examine these mechanisms in vivo, rats were exposed to a lateral fluid percussion injury (FPI). FPI caused increased neuronal protein nitration that colocalized with TUNEL staining, indicating that PN was associated with neurodegeneration. Caspase-3 activity was inhibited in brain lysates harvested after FPI and was restored by adding dithiothreitol. Our data show that caspase-mediated apoptosis is inhibited in neurons subjected to stretch in vitro and to TBI in vivo, mostly because of cysteinyl oxidation of caspase-3 by PN. However, this is insufficient to prevent cell death, indicating that the TBI therapy may, at a minimum, require a combination of both anti-apoptotic and anti-oxidant strategies.

Key words: peroxynitrite; traumatic brain injury; caspase-3; apoptosis; nitric oxide; reactive oxygen species


Received May 1, 2006; revised Aug. 13, 2006; accepted Sept. 17, 2006.

Correspondence should be addressed to Dr. Michael Tymianski, Fellow of the Royal College of Surgeons of Canada, Toronto Western Hospital, WW 4-435, 399 Bathurst Street, Toronto, Ontario, Canada M5T 2S8. Email: mike.tymianski{at}uhn.on.ca


Related articles in J. Neurosci.:

Molecular Cross Talk in Traumatic Brain Injury
Joshua D. Bell
J. Neurosci. 2007 27: 2153-2154. [Full Text]  



This article has been cited by other articles:


Home page
CMAJHome page
E. Park PhD, J. D. Bell BSc, and A. J. Baker MD
Traumatic brain injury: Can the consequences be stopped?
Can. Med. Assoc. J., April 22, 2008; 178(9): 1163 - 1170.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. D. Bell
Molecular Cross Talk in Traumatic Brain Injury
J. Neurosci., February 28, 2007; 27(9): 2153 - 2154.
[Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-